Nearly 30 percent of women fail to pick up new prescriptions for osteoporosis
- Details
- Category: Research
Nearly 30 percent of women failed to pick up their bisphosphonate prescriptions, a medication that is most commonly used to treat osteoporosis and similar bone diseases, according to a Kaiser Permanente study published this week in the journal Osteoporosis International. The failure to pick up these newly prescribed medications, called primary nonadherence, can lead to an increased risk of fractures for these patients.
Treatment for novel coronavirus shows promise in early lab tests
- Details
- Category: Research
National Institutes of Health (NIH) scientists studying an emerging coronavirus have found that a combination of two licensed antiviral drugs, ribavirin and interferon-alpha 2b, can stop the virus from replicating in laboratory-grown cells. These results suggest that the drug combination could be used to treat patients infected with the new coronavirus, but more research is needed to confirm this preliminary finding.
New study finds digoxin safe despite recent reports
- Details
- Category: Research
A study published in the European Heart Journal found no evidence that digoxin increases mortality in patients with atrial fibrillation (AF), the opposite of results just published by another group in the same journal analyzing the same data. Older patients with AF also often have heart failure, and digoxin is approved to treat both conditions.
Key bone marrow protein identified as potential new leukemia treatment target
- Details
- Category: Research
A new study on how the progression of acute lymphocytic leukemia (ALL) is influenced by the bone marrow environment has demonstrated for the first time that targeting a specialized protein known as osteopontin (OPN) may be an effective strategy to increase the efficacy of chemotherapy in patients with this type of blood cancer. Study data were published online in Blood, the Journal of the American Society of Hematology (ASH).
Arrhythmia drug may increase cancer risk
- Details
- Category: Research
One of the most widely used medications to treat arrhythmias may increase the risk of developing cancer, especially in men and people exposed to high amounts of the drug. That is the conclusion of a new retrospective study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The study's results indicate that a potential link between amiodarone and cancer warrants further investigation.
The finding in search for neurodegenerative disease treatments
- Details
- Category: Research
A significant breakthrough has been made by scientists at The University of Manchester towards developing an effective treatment for neurodegenerative diseases such as Huntington's, Alzheimer's and Parkinson's. Researchers at the Manchester Institute of Biotechnology have detailed how an enzyme in the brain interacts with an exciting drug-like lead compound for Huntington's Disease to inhibit its activity.
Treatments, not prevention, dominate diabetes research
- Details
- Category: Research
Research for diabetes is far more focused on drug therapies than preventive measures, and tends to exclude children and older people who have much to gain from better disease management, according to a Duke Medicine study. By analyzing nearly 2,500 diabetes-related trials registered in ClinicalTrials.gov from 2007-10, the authors provide a broad overview of the research landscape for diabetes.
More Pharma News ...
- The combined HER2 targeted therapy without chemotherapy
- Study reveals that chemotherapy works in an unexpected way
- New relief for gynecological disorders
- New nanomedicine resolves inflammation, promotes tissue healing
- Newly approved blood thinner may increase susceptibility to some viral infections
- Genetic 'spelling mistakes' that increase the risk of common cancers
- T-cell therapy eradicates an aggressive leukemia in 2 children